Loading... Please wait...

Navidea Biopharmaceuticals, Inc. (NAVB) Financials

Currency in USD Disclaimer
$0
$0
$1
$4
Notice: This company has been marked as potentially delisted and may not be actively trading.
Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $65,652.00 $531,513.00 $915,013.00 $26,618.00 $322,521.00 $1.81 M $21.97 M $13.25 M $6.27 M $1.13 M
Cost of Revenue $184,947.00 $0.00 $1,048.00 $6,667.00 $96,636.00 $3,651.00 $2.30 M $1.75 M $1.59 M $332,815.00
Gross Profit -$119,295.00 $531,513.00 $913,965.00 $19,951.00 $225,885.00 $1.81 M $19.67 M $11.49 M $4.69 M $797,815.00
Gross Profit Ratio -1.82 1 1 0.75 0.7 1 0.9 0.87 0.75 0.71
Research and Development Expenses $5.97 M $5.14 M $4.93 M $5.34 M $4.22 M $4.51 M $8.88 M $12.79 M $16.78 M $23.71 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $7.70 M $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.96 M $7.45 M $6.69 M $6.28 M $7.70 M $11.17 M $13.01 M $17.26 M $15.54 M $15.53 M
Other Expenses -$27,939.00 -$14,115.00 -$21,855.00 -$631,208.00 $1,145.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $13.93 M $12.59 M $11.63 M $10.98 M $11.07 M $15.68 M $21.90 M $30.05 M $32.32 M $39.24 M
Cost And Expenses $14.12 M $12.59 M $11.63 M $10.99 M $11.17 M $15.69 M $24.19 M $31.80 M $33.91 M $39.57 M
Interest Income $326,000.00 $6,000.00 $11,344.00 $25,000.00 $0.00 $0.00 $0.00 $0.00 $16,102.00 $18,838.00
Interest Expense $1.10 M $6,361.00 $0.00 $25,288.00 $30,799.00 $168,971.00 -$14.86 M -$6.87 M $3.71 M $2.78 M
Depreciation & Amortization $95,819.00 -$366,000.00 $70,393.00 $144,512.00 $150,385.00 $254,587.00 $501,369.00 $571,419.00 $500,183.00 $404,181.00
EBITDA -$14.05 M -$12.43 M -$10.71 M -$10.96 M -$5.56 M -$9.80 M -$4.51 M -$15.22 M -$28.16 M -$38.44 M
EBITDA Ratio -214.02 -23.38 -11.71 -411.85 -17.23 -5.41 -0.21 -1.15 -4.49 -34
Operating Income -$14.05 M -$12.06 M -$10.71 M -$10.96 M -$10.85 M -$13.88 M -$2.22 M -$18.55 M -$27.63 M -$38.44 M
Operating Income Ratio -214.02 -22.69 -11.71 -411.85 -33.63 -7.67 -0.1 -1.4 -4.4 -34
Total Other Income/Expenses Net -$1.13 M $345,524.00 -$10,511.00 $17,675.00 -$5.29 M -$4.08 M $2.78 M -$3.33 M -$4.39 M -$1.48 M
Income Before Tax -$15.18 M -$11.71 M -$10.72 M -$10.94 M -$16.17 M -$17.79 M -$14.31 M -$28.76 M -$35.73 M -$42.70 M
Income Before Tax Ratio -231.18 -22.04 -11.72 -411.18 -50.13 -9.83 -0.65 -2.17 -5.69 -37.77
Income Tax Expense $2.04 M $16,043.00 -$81,737.00 $707.00 $2,747.00 -$4.06 M -$648,000.00 -$436,051.00 $2.68 M $2.37 M
Net Income -$17.22 M -$11.73 M -$10.64 M -$10.95 M -$16.13 M $74.95 M -$14.31 M -$27.56 M -$35.73 M -$42.70 M
Net Income Ratio -262.22 -22.07 -11.63 -411.21 -50 41.4 -0.65 -2.08 -5.69 -37.77
EPS -0.59 -0.4 -0.45 -0.76 -1.89 9.4 -1.84 -3.65 -4.8 -7.01
EPS Diluted -0.59 -0.4 -0.45 -0.76 -1.89 9 -1.84 -3.65 -4.8 -7.01
Weighted Average Shares Out $29.34 M $29.34 M $23.90 M $14.39 M $8.53 M $8.08 M $7.77 M $7.56 M $7.44 M $6.09 M
Weighted Average Shares Out Diluted $29.34 M $29.34 M $23.90 M $14.39 M $8.53 M $8.30 M $7.77 M $7.56 M $7.44 M $6.09 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.